Meeting
2013 Gastrointestinal Cancers Symposium
16-covariate propensity score matching between trimodality (TMT)-eligible esophagogastric cancer (EC) patients who had surgery and those who declined surgery after preoperative chemoradiation.
Authors
Takashi Taketa
The University of Texas MD Anderson Cancer Center
Takashi Taketa , Lianchun Xiao , Akihiro Suzuki , Mariela Blum , Kazuki Sudo , Jeffrey Lee , Brian Weston , Manoop Bhutani , Steven Lin , Roopma Wadhwa , Stephen Swisher , Wayne Hofstetter , Jaffer Ajani
Disclaimer
This material on this page is ©2024 American Society of Clinical Oncology, all rights reserved. Licensing available upon request. For more information, please contact licensing@asco.org
Poster Details
Session Type
Poster Session
Session Title
General Poster Session A: Cancers of the Esophagus and Stomach
Track
Cancers of the Esophagus and Stomach
Sub Track
Multidisciplinary Treatment
Citation
J Clin Oncol 31, 2013 (suppl 4; abstr111)
DOI
10.1200/jco.2013.31.4_suppl.111
Abstract #
111
Poster Bd #
B55
Abstract Disclosures
Similar Posters
Poster
2012 Gastrointestinal Cancers Symposium
Outcome of trimodality-eligible esophagogastric cancer (EC) patients who declined surgery after preoperative chemoradiation.
First Author: Takashi Taketa
Poster
2023 ASCO Gastrointestinal Cancers Symposium
Trimodality therapy with carboplatin/paclitaxel (CP) or FOLFOX (FFX) for esophageal/esogastric junctional cancer (EC/EGJ): Expanded safety and efficacy data from PROTECT.
First Author: Antoine Adenis
Poster
2016 ASCO Annual Meeting
The impact of sex, race, and socioeconomic status (SES) on outcomes in 6,870 patients with esophageal cancer.
First Author: Phu N. Tran
Poster
2016 ASCO Annual Meeting
Influence of induction chemotherapy (IC) in trimodality-eligible esophageal cancer patients: Secondary analysis of a randomized trial.
First Author: Yusuke Shimodaira